Experts worry insulin getting too expensive for many in U.S. and worldwide

Eric Palmer Healthcare professionals are concerned that hormone insulin meds, often the key diabetes treatment, are getting too costly for many patients, even in the U.S. In developing ...

Globalization: Another year closer to a worldwide network

John Carroll When AstraZeneca announced its move to create its third R&D hub in China, the pharma giant was following in the paths of some major rivals. It also represented another ...

Eisai bets another $60M on Arena’s Belviq with worldwide marketing deal

Tracy Staton Eisai gave Arena Pharmaceuticals' obesity drug Belviq another vote of confidence. The Japanese drugmaker, already marketing the drug in the U.S., signed up to promote ...

Actavis Acquires Worldwide Rights for Palau Pharma’s Albaconazole Antifungal Agent

barbara.lempert PARSIPPANY, N.J. and BARCELONA, SPAIN, Aug. 6, 2013 /PRNewswire/ — Actavis, Inc. (NYSE: ACT) and Palau Pharma, S.A. today announced that Actavis Specialty Brands ...

BBK Worldwide launches new patient engagement tool via Google Virtual Tours

mia.burns By Mia Burns A new online tool from BBK Worldwide is now available that uses Google virtual Business Photos to create virtual tours of clinical research study locations for ...

Sequella Acquires Exclusive Worldwide Rights to Pfizer’s Sutezolid

barbara.lempert Sequella Acquires Exclusive Worldwide Rights to Pfizer’s Sutezolid, Currently in Clinical Development for Tuberculosis Sequella Obtains Development and Commercialization ...

BBK Worldwide Mobilizes 7,000 Attendees of the Drug Information Association

barbara.lempert Annual Meeting to Be “Boston Strong”   Demonstrating the Power of Mobile Marketing, BBK Will Donate $ 5 to The One Fund Boston for Every “Boston Strong” ...
© 2017 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS